Clinical Trial Update: A Study of Sovilnesib in Subjects With Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 study update of Sovilnesib in gynecologic cancers; the trial is active but not recruiting, investigating high-grade serous ovarian cancer, fallopian tub…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• High-grade Serous Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Sovilnesib (Sovilnesib)

Snippet

Sponsor: Volastra Therapeutics, Inc. | Conditions: High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING